Interestingly, low doses of SKA IFN-γ have been found to enhance the ex vivo cytotoxic activity of NK cells from patients with early-stage colon cancer [17], thus suggesting that low doses of SKA IFN-γ have an immunomodulatory effect. Here, IFNG is linked to malignant colon neoplasm.